New England Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-229
Closed -$5K 169
2022
Q3
$5K Buy
+229
New +$6.91K ﹤0.01% 182
2022
Q2
Sell
-60
Closed -$2K 180
2022
Q1
$2K Sell
60
-55
-48% -$1.88K ﹤0.01% 161
2021
Q4
$4K Hold
115
﹤0.01% 170
2021
Q3
$4K Sell
115
-6,821
-98% -$218K ﹤0.01% 172
2021
Q2
$209K Buy
+6,936
New +$228K ﹤0.01% 127

Other funds holding OGN

New England Asset Management's OGN Position: Q4 2022 in Review

New England Asset Management sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 229 shares — an estimated $5K sold.

New England Asset Management first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $209K in Q2 2021. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • New England Asset Management reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • New England Asset Management sold 229 Organon & Co shares in Q4 2022, an estimated $5K.
  • New England Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • New England Asset Management's Organon & Co position peaked at $209K in Q2 2021.
  • 821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on New England Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.